col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


111 Results       Page 1

 [1] 
SAGE Publications: Clinical and Applied Thrombosis/Hemostasis
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―29 Sex Differences and Clinical Outcomes of Patients with Coronavirus Disease 2019 Infection and Cerebral Venous Sinus Thrombosis: A Systematic Review Saleh A. Algarni, Naif S. ALGhasab, Mohammed S. Alharbi, Anas Albarrak, Ahmad A. Alanezi, Hamdan M. Al Shehri
2 [GO] 2023―Dec―15 Impact of Concomitant Thrombotic Thrombocytopenic Purpura on COVID-19 Mortality and Morbidity: A Nationwide Inpatient Sample Analysis Ali Jaan, Zouina Sarfraz, Farhan Khalid, Junaid Anwar
3 [GO] 2023―Dec―11 The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Ramesh Vishwakarma, Mashael AlFaifi, et al. (+14)
4 [GO] 2023―Oct―30 Impact of New Onset Atrial Fibrillation in Hospitalized Patients with COVID-19. Results of the “ACO-VID” Registry Juan José Cerezo Manchado, Teodoro Iturbe Hernández, María del Carmen Martínez Pacheco, Ignacio Gil Ortega, Desirée Campoy, Tania Canals Pernas, et al. (+6)
5 [GO] 2023―Aug―07 Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis Awatif Hafiz, Hadeel Alkofide, Khalid Al Sulaiman, Hala Joharji, Sarah Aljohani, Khadijah A. Sarkhi, et al. (+5)
6 [GO] 2023―Jul―05 Mean Platelet Volume may not be an Indicator of the Risk of Venous Thrombosis in COVID-19 Patients Cengiz Beyan, Esin Beyan
7 [GO] 2023―Jun―16 Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Lina I. Alnajjar, Ali F. Altebainawi, Mashael AlFaifi, et al. (+19)
8 [GO] 2023―Jun―07 Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation Pável Olivera, César Velásquez-Escandón, Desirée Campoy, Katia Flores, Tania Canals, Erik Johansson, et al. (+4)
9 [GO] 2023―May―25 Lymphocytes, Mean Platelet Volume, and Albumin in Critically Ill COVID-19 Patients with Venous Thromboembolism Rundan Duan, Qihong Ni, Yinan Li, Mingli Zhu, Wen Li, Peng Wang, et al. (+5)
10 [GO] 2023―May―19 Thrombosis Occurrence in COVID-19 Compared With Other Infectious Causes of ARDS: A Contemporary Cohort Andréa Coy-Canguçu, Gisele A. Locachevic, João Carlos S. Mariolano, Kaio Henrique De O. Soares, José Diogo Oliveira, Camila De Oliveira Vaz, et al. (+5)
11 [GO] 2023―May―03 Efficacy and Safety of Direct Oral Anticoagulants Compared With Heparin for Preventing Thromboembolism in Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis Yong Tian, Tao Pan, Xudong Wen, Guangyu Ao, Yihan Ma, Xiaoxiao Liu, et al. (+2)
12 [GO] 2023―Feb―15 Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19 Raed Kensara, Ohoud Aljuhani, Ghazwa B Korayem, Hadeel Alkofide, Sumaya N Almohareb, Yousef S Alosaimi, et al. (+19)
13 [GO] 2023―Feb―01 The Efficacy and Safety of Prolonged Oral Anticoagulation for the Prevention of Thromboembolic Events in Patients Recovered From COVID-19 1 Year After Hospital Discharge: The SARCOV-19 Prospective Registry Ghizlane El Aidouni, Amine Bouchlarhem, Houssam Bkiyar, Nabila Ismaili, Noha El Ouafi, Brahim Housni
14 [GO] 2023―Jan―03 Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis Forough Mehrabi, Melina Farshbafnadi, Nima Rezaei
15 [GO] 2022―Dec―27 Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) Daniel Aston, Martin Besser, Ben Goddard, Nicholas Maggs, Hassan Ahmed, Florian Falter
16 [GO] 2022―Dec―23 Correction of Anticoagulant Therapy in Patients with Severe COVID-19 Virus Infection Using a Thrombodynamics Coagulation Assay Tatiana S. Vuimo, Sergey V. Tsarenko, Elena V. Filimonova, Elena A. Seregina, Sergey S. Karamzin
17 [GO] 2022―Dec―14 The Impact of Prior Antithrombotic use on Thromboembolic Events in Patients with Cardiovascular Disease and Severe COVID-19 Infection Amine Bouchlarhem, Soumia Boulouiz, Ghizlane el Aidouni, Houssam Bkiyar, Zakaria Bazid, Nabila Ismaili, et al. (+2)
18 [GO] 2022―Nov―17 Recent Findings on Platelet Activation, vWF Multimers and Other Thrombotic Biomarkers Associated with Critical COVID-19 Guadalupe Damián-Vázquez, Nallely García-Larragoiti, Alan Cano-Méndez, Patricia Guzmán-Cancino, Aidyl Tiznado-Leyva, Sandra López-Castaneda, Martha Eva Viveros-Sandoval
19 [GO] 2022―Nov―12 Assessment of Healthcare Resource Utilization by Anticoagulant Heparinoid Dosage Level in Patients Hospitalized with COVID-19 Keith Robinson, Laura L. Schott, Tom Matthews, Manu Tyagi, Vivek B. Ajmani, Nancy Sacco, Zhun Cao
20 [GO] 2022―Oct―26 In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin Moudhi Alroomi, Ahmad Alsaber, Bader Al-Bader, Farah Almutairi, Haya Malhas, Jiazhu Pan, et al. (+9)
21 [GO] 2022―Sep―29 Association of Lupus Anticoagulant status with Disease Course in SARS-CoV-2 (COVID-19) Infection Suhyeon Woo, Bohyun Kim, Nam Hun Heo, Min-sun Kim, Young Ahn Yoon, Young-Jin Choi
22 [GO] 2022―Aug―23 Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United States W. Frank Peacock, James M. Crawford, Yen-Wen (Cindy) Chen, Veronica Ashton, Alicia K. Campbell, Dejan Milentijevic, Alex C. Spyropoulos
23 [GO] 2022―Aug―09 D-dimer Thresholds to Exclude Pulmonary Embolism among COVID-19 Patients in the Emergency Department: Derivation with Independent Validation Joseph R. Bledsoe, Daniel Knox, Ithan D. Peltan, Scott C. Woller, James F. Lloyd, Gregory L. Snow, et al. (+3)
24 [GO] 2022―Aug―04 Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019 Adham Mohamed, Shelby M Shemanski, Mohamed O Saad, Jeannette Ploetz, Michelle M Haines, Andrew B Schlachter, Majdi S Hamarshi
25 [GO] 2022―Jul―29 Clot Stiffness Measured By Seer Sonorheometry As a Marker Of Poor Prognosis In Hospitalized COVID-19 Patients Francisco José López-Jaime, Ihosvany Fernández-Bello, Sandra Martín-Téllez, Alberto Doblas-Márquez, Yohannes Tesfay, Ignacio Márquez-Gómez, et al. (+3)
26 [GO] 2022―Jul―18 Development and Implementation of an Online Global Pharmacovigilance Certificate Program During the COVID-19 Pandemic Thao Doan, Fabio Lievano, Linda Scarazzini, Kate Liebelt, Mark Jaradeh, Bulent Kantarcioglu, et al. (+2)
27 [GO] 2022―Jun―29 Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19 Wei Xia, Yafeng Tan, Shengmei Hu, Chengbin Li, Tao Jiang
28 [GO] 2022―Jun―14 COVID-19 Infection in Patients with Comorbidities: Clinical and Immunological Insight Omnia El-Badawy, Nahla M. Elsherbiny, Doaa Abdeltawab, Doaa M. Magdy, Lamees M. Bakkar, Shimaa A. Hassan, et al. (+12)
29 [GO] 2022―Jun―06 Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study Shmeylan Al Harbi, Raed Kensara, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Abdullah Al Harthi, et al. (+18)
30 [GO] 2022―May―10 Correspondence on COVID-19 Vaccination and Acquired Haemophila A Pathum Sookaromdee, Viroj Wiwanitkit
31 [GO] 2022―Apr―05 Haemostatic Disarray Following COVID-19 Vaccine - a Case of Acquired Haemophila A Evelyn O'Shea, Orna Daly, Cleona Duggan, Maeve Crowley
32 [GO] 2022―Apr―01 Acute Myocardial Injury Assessed by High-Sensitive Cardiac Troponin Predicting Severe Outcomes and Death in Hospitalized Patients with COVID-19 Infection Falmata Laouan Brem, Miri Chaymae, Hammam Rasras, Manal Merbouh, Mohammed-Amine Bouazzaoui, Houssam Bkiyar, et al. (+5)
33 [GO] 2022―Mar―29 Rotational Thromboelastometry Profile among Critically ill COVID-19 Patients Indalecio Carboni Bisso, Iván Huespe, Eduardo Prado, Melina Garbarini, Marina Sol López, Luis Barrera, et al. (+3)
34 [GO] 2022―Mar―25 Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients? Győző Szolnoky, Alejandro José González-Ochoa
35 [GO] 2022―Mar―21 Report of Low Incidence of Thrombosis with Early Prophylaxis in Hospitalized Patients with COVID-19 from Two Saudi Tertiary Centers Tarek Owaidah, Khalid Maghrabi, Feras Alfraih, Alfadil Haroon, Khawar Siddiqui, Randa Alnounou, et al. (+5)
36 [GO] 2022―Mar―21 Factor VIII, Fibrinogen and Heparin Resistance in COVID-19 Patients with Thromboembolism: How Should We Manage the Anticoagulation Therapy? Felicio Savioli, Maurício Claro, Fernando Jose da Silva Ramos, Laerte Pastore
37 [GO] 2022―Mar―18 Improving Care of Older Patients with Hemophilia During COVID-19 Pandemic, Reducing the Risk of Venous Thrombosis with Home Exercises Ufuk Demirci, Elif G. Umit, Hande Ozdemir, Derya Demirbag Kabayel, Ahmet Muzaffer Demir
38 [GO] 2022―Mar―11 Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia Guillaume Roberge, Marc Carrier
39 [GO] 2022―Feb―15 An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations Bulent Kantarcioglu, Omer Iqbal, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio Lievano, et al. (+5)
40 [GO] 2022―Feb―02 Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination Mona Al-Ahmad, Mona Al Rasheed, Neveen Shalaby, Tito Rodriguez-Bouza, Lulwa Altourah
41 [GO] 2022―Jan―24 Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review Michael Joseph Cryer, Serdar Farhan, Christoph C. Kaufmann, Bernhard Jäger, Aakash Garg, Prakash Krishnan, et al. (+2)
42 [GO] 2021―Dec―22 Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis Rostami Mehrdad, Khoshnegah Zahra, Hassan Mansouritorghabeh
43 [GO] 2021―Dec―15 Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Susan Guy, Steve Kitchen, Michael Makris, Rhona M. Maclean, Giorgia Saccullo, Joost J Vanveen
44 [GO] 2021―Dec―15 Thrombotic and Hemorrhagic Incidences in Patients After Discharge from COVID-19 Infection: A Systematic Review and Meta-Analysis Tarinee Rungjirajittranon, Weerapat Owattanapanich, Nattawut Leelakanok, Natthaporn Sasijareonrat, Bundarika Suwanawiboon, Yingyong Chinthammitr, Theera Ruchutrakool
45 [GO] 2021―Dec―15 Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey Bulent Kantarcioglu, Krishan Patel, Joseph Lewis, Omer Iqbal, Fakiha Siddiqui, Nusrat Jabeen, et al. (+3)
46 [GO] 2021―Dec―15 Diagnostic Accuracy of D-Dimers for Predicting Pulmonary Embolism in COVID-19-Patients Falmata Laouan Brem, Boudouh Asmae, Yassine Amane, Mohammed-Amine Bouazzaoui, Miri Chaymae, Hammam Rasras, et al. (+7)
47 [GO] 2021―Dec―15 Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review Usama Waqar, Shaheer Ahmed, Syed M.H.Ali Gardezi, Muhammad Sarmad Tahir, Zain ul Abidin, Ali Hussain, et al. (+2)
48 [GO] 2021―Nov―17 D-dimer, COVID-19 and Diabetes: A Correspondence Sora Yasri, Viroj Wiwanitkit
49 [GO] 2021―Nov―17 Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study Heidi Worth, Kasey Helmlinger, Renju Raj, Eric Heidel, Ronald Lands
50 [GO] 2021―Nov―15 Extensive Arterial, Venous and Intracardiac Thrombosis in a Patient After Recovery From COVID-19 Priyal Agarwal, Issa Haddad
51 [GO] 2021―Nov―10 A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19 Mark Klein, Vinh Dao, Fatima Khan
52 [GO] 2021―Nov―10 Thrombosis After Adenovirus-Vectored COVID-19 Vaccination: A Concern on Underlying Illness Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
53 [GO] 2021―Oct―29 Significance of MPV, RDW and PDW with the Severity and Mortality of COVID-19 and Effects of Acetylsalicylic Acid Use Faruk Aydınyılmaz, Emrah Aksakal, Hilal Erken Pamukcu, Selim Aydemir, Remziye Doğan, İbrahim Saraç, et al. (+4)
54 [GO] 2021―Oct―29 Low Incidence of Symptomatic Thrombotic Events in Adult Patients Hospitalized with Coronavirus 19: A Retrospective Cohort Study Marcelo G. Vallone, Carolina Vazquez, Fernando A. Chuliber, Verónica Privitera, Augusto Ferraris, Ramiro F. Cantarella, et al. (+4)
55 [GO] 2021―Oct―26 COVID-19 Vaccine-Associated Thrombosis With Thrombocytopenia Syndrome (TTS): A Systematic Review and Post Hoc Analysis Muhammad Usman Hafeez, Maha Ikram, Zunaira Shafiq, Azza Sarfraz, Zouina Sarfraz, Vikash Jaiswal, et al. (+2)
56 [GO] 2021―Oct―25 Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum? Patrick Van Dreden, Jawed Fareed, Ismail Elalamy, Grigoris Gerotziafas
57 [GO] 2021―Oct―23 Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19 Zahra Elyaspour, Mohammad Javad Zibaeenezhad, Mahboobeh Razmkhah, Iman Razeghian-Jahromi
58 [GO] 2021―Oct―01 Anticoagulation for COVID-19 Patients: A Bird's-Eye View Firas Kreidieh, Sally Temraz
59 [GO] 2021―Sep―30 D-dimer Level and Diabetes in the COVID-19 Infection Chaymae Miri, Hajar Charii, Mohammed-Amine Bouazzaoui, Falmata Laouan Brem, Soumia boulouiz, Naima Abda, et al. (+4)
60 [GO] 2021―Sep―30 Dengue After COVID-19 Vaccination: Possible and Might be Missed Amnuay Kebayoon, Viroj Wiwanitkit
61 [GO] 2021―Sep―20 Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination MA Haimei
62 [GO] 2021―Sep―09 Safety Interval From Increased Viscosity After COVID-19 Vaccination Among Persons With Cerebrovascular Problems Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
63 [GO] 2021―Jun―30 Acetylsalicylic Acid and COVID-19 Prevention: A Comment Pathum Sookaromdee, Viroj Wiwanitkit
64 [GO] 2021―Jun―29 Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity Mehmet Gökhan Gönenli, Zeynep Komesli, Said İncir, Özlem Yalçın, Olga Meltem Akay
65 [GO] 2021―Jun―25 Clinical Features of COVID-19 Patients With Venous Thromboembolism Kai Liang, Ying Fu, Yi Kang, Huanzhang Shao, Jianxu Yang, Mingzhe Cui, Shuiting Zhai
66 [GO] 2021―Jun―18 Evaluation of Bleeding Rate and Time in Therapeutic Range in Patients Using Warfarin Before and During the COVID-19 Pandemic-Warfarin Treatment in COVID-19 Zeynep Yapan Emren, Oktay Şenöz, Ahmet Erseçgin, Sadık Volkan Emren
67 [GO] 2021―Jun―18 Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19 Beuy Joob, Viroj Wiwanitkit
68 [GO] 2021―Jun―02 An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination Bulent Kantarcioglu, Omer Iqbal, Jeanine M. Walenga, Bruce Lewis, Joseph Lewis, Charles A. Carter, et al. (+7)
69 [GO] 2021―May―21 Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy Radu Crisan-Dabija, Alexandru Burlacu
70 [GO] 2021―May―20 The Meaning of D-Dimer value in Covid-19 Giulia Conte, Marco Cei, Isabella Evangelista, Alessandra Colombo, Josè Vitale, Antonino Mazzone, Nicola Mumoli
71 [GO] 2021―Apr―30 Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients? Federico Cacciapuoti, Fulvio Cacciapuoti
72 [GO] 2021―Apr―30 Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression Haoting Zhan, Haizhen Chen, Chenxi Liu, Linlin Cheng, Songxin Yan, Haolong Li, Yongzhe Li
73 [GO] 2021―Apr―28 Blood Viscosity at the First Clinical Presentation in Fatal and Non-Fatal COVID-19: An Observation Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
74 [GO] 2021―Apr―20 Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Chatphatai Moonla, Darintr Sosothikul, Thita Chiasakul, Ponlapat Rojnuckarin, Noppacharn Uaprasert
75 [GO] 2021―Apr―09 Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection Sandra Lopez-Castaneda, Nallely García-Larragoiti, Alan Cano-Mendez, Kenia Blancas-Ayala, Guadalupe Damian-Vázquez, Ana Itzel Perez-Medina, et al. (+3)
76 [GO] 2021―Apr―08 ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study Joel G. Ray, Marian J. Vermeulen, Michael J. Schull, Alison L. Park
77 [GO] 2021―Apr―05 Clinical Outcomes of Pulmonary Embolism in Mexican Patients With COVID-19 Luis O. Bobadilla-Rosado, Santiago Mier y Teran-Ellis, Gabriel Lopez-Pena, Javier E. Anaya-Ayala, Carlos A. Hinojosa
78 [GO] 2021―Mar―31 Role of Tissue Factor in the Pathogenesis of COVID-19 and the Possible Ways to Inhibit It Carlos A. Cañas, Felipe Cañas, Mario Bautista-Vargas, Fabio Bonilla-Abadía
79 [GO] 2021―Mar―30 Considerations for Patients With Peripheral Artery Disease During the COVID-19 Pandemic Serdar Farhan, Haroon Kamran, Birgit Vogel, Karan Garg, Ajit Rao, Navneet Narula, et al. (+9)
80 [GO] 2021―Mar―24 Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose Zhenzhou Wang, Zhe Du, Xiujuan Zhao, Fuzheng Guo, Tianbing Wang, Fengxue Zhu
81 [GO] 2021―Feb―11 Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis Azza Sarfraz, Zouina Sarfraz, Aminah Abdul Razzack, Gaurav Patel, Muzna Sarfraz
82 [GO] 2021―Feb―10 Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection Harry N. Magnani
83 [GO] 2021―Jan―15 Systemic Coagulopathy in Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Noppacharn Uaprasert, Chatphatai Moonla, Darintr Sosothikul, Ponlapat Rojnuckarin, Thita Chiasakul
84 [GO] 2020―Dec―29 Deep Venous Thrombosis in COVID-19 Patients: A Cohort Analysis Chuanqi Cai, Yi Guo, Yun You, Ke Hu, Fei Cai, Mingxing Xie, et al. (+6)
85 [GO] 2020―Oct―20 COVID-19 and Hypercoagulability: A Review Asim Kichloo, Kirk Dettloff, Michael Aljadah, Michael Albosta, Shakeel Jamal, Jagmeet Singh, et al. (+4)
86 [GO] 2020―Oct―20 The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review Indra Wijaya, Rizky Andhika, Ian Huang
87 [GO] 2020―Oct―20 Prevalence and Risk Factors of Thromboembolism among Patients With Coronavirus Disease-19: A Systematic Review and Meta-Analysis Belayneh Kefale, Gobezie T. Tegegne, Amsalu Degu, Melaku Tadege, Desalegn Tesfa
88 [GO] 2020―Oct―15 Is Thrombophilic Genetic Profile Responsible for an Acute Ischemic Stroke in a COVID-19 Male Patient? Alexandru Burlacu, Bogdan Artene, Radu Crisan-Dabija, Iolanda Valentina Popa, Adrian Covic
89 [GO] 2020―Oct―08 A Retrospective Analysis of the Coagulation Dysfunction in COVID-19 Patients Xu Chen, Qinghua Wang, Min Xu, Chengbin Li
90 [GO] 2020―Sep―16 Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review Nicholas Kipshidze, Patrick Iversen, Thomas R. Porter, Nodar Kipshidze, Fakiha Siddiqui, George Dangas, Jawed Fareed
91 [GO] 2020―Sep―16 Anticoagulation in COVID-19: DDI Perspective Sajad Khiali, Taher Entezari-Maleki
92 [GO] 2020―Sep―04 Methodological Issues and Controversies in COVID-19 Coagulopathy: A Tale of Two Storms Samuel A Berkman, Victor F Tapson
93 [GO] 2020―Sep―02 Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 Pandemic Faisal Alsayegh, Shaker A. Mousa
94 [GO] 2020―Aug―28 Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients Yuan Yu, Jie Tu, Bingxin Lei, Huaqing Shu, Xiaojing Zou, Ruiting Li, et al. (+3)
95 [GO] 2020―Aug―26 COVID-19, Antiphospholipid Syndrome and Thrombosis Sora Yasri, Viroj Wiwanitkit
96 [GO] 2020―Aug―26 Unpuzzling COVID-19 Prothrombotic State: Are Preexisting Thrombophilic Risk Profiles Responsible for Heterogenous Thrombotic Events? Alexandru Burlacu, Simonetta Genovesi, Iolanda Valentina Popa, Radu Crisan-Dabija
97 [GO] 2020―Aug―21 Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic Kaveh Rezaei Bookani, Iva Minga, Manisha Chander, Ksenia Hankewych, Matthew Plassmeier, Alfonso Tafur
98 [GO] 2020―Aug―14 COVID-19 Associated Coagulopathy and Thrombotic Complications Zoubida Tazi Mezalek, Hajar Khibri, Wafaa Ammouri, Majdouline Bouaouad, Soukaina Haidour, Hicham Harmouche, et al. (+2)
99 [GO] 2020―Jul―31 COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response Apoorva Jayarangaiah, Pramod Theetha Kariyanna, Xiaoyi Chen, Amog Jayarangaiah, Abhishek Kumar
100 [GO] 2020―Jul―31 Coronavirus Disease and Acute Vascular Events Gundu H. R. Rao
101 [GO] 2020―Jul―29 Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan Jianpu Chen, Xiang Wang, Shutong Zhang, Bin Lin, Xiaoqing Wu, Yanfang Wang, et al. (+4)
102 [GO] 2020―Jul―29 Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications MA Haimei
103 [GO] 2020―Jul―24 Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19 Galit H. Frydman, Edward W. Boyer, Rosalynn M. Nazarian, Elizabeth M. Van Cott, Gregory Piazza
104 [GO] 2020―Jul―22 Pulmonary Embolism, Pulmonary Microvascular Thrombosis, or Both in COVID-19? José A. Páramo
105 [GO] 2020―Jul―20 Viral Coagulopathy in Patients With COVID-19: Treatment and Care Nickolas Kipshidze, George Dangas, Christopher J. White, Nodar Kipshidze, Fakiha Siddiqui, Christopher R. Lattimer, et al. (+2)
106 [GO] 2020―Jul―17 COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation Wolfgang Miesbach, Michael Makris
107 [GO] 2020―Jul―13 Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium? Nil Guler, Fakiha Siddiqui, Jawed Fareed
108 [GO] 2020―Jul―10 Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020 Eduardo Ramacciotti, Ariane Scarlatelli Macedo, Rodrigo Bruno Biagioni, Roberto Augusto Caffaro, Renato Delascio Lopes, João Carlos Guerra, et al. (+8)
109 [GO] 2020―Jul―10 Reducing the Risk of Venous Thrombosis During Self-Isolation and COVID-19 Pandemic for Patients With Cancer: Focus on Home Exercises Prescription Ufuk Demirci, Hande Ozdemir, Derya Demirbag-Kabayel, Elif G. Umit, Ahmet Muzaffer Demir
110 [GO] 2020―Jul―03 COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets Erkan Cure, Medine Cumhur Cure
111 [GO] 2020―Apr―06 Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients Beuy Joob, Viroj Wiwanitkit
 [1] 

111 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.017 sec